We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GI Dynamics’ Diabetes/Obesity Device to Skip Pilot, Go Straight to Pivotal Trial
GI Dynamics’ Diabetes/Obesity Device to Skip Pilot, Go Straight to Pivotal Trial
August 31, 2012
The FDA has given Lexington, Mass.-based GI Dynamics a conditional go-ahead to launch a pivotal clinical trial of its EndoBarrier for obese patients with Type 2 diabetes.